Supreme Court Ruling Overturns Purdue Pharma's $6 Billion Settlement
The decision impacts future bankruptcy settlements and the Sackler family's financial liability.
- The Supreme Court's 5-4 decision nullifies Purdue Pharma's $6 billion opioid settlement.
- This ruling changes how Chapter 11 bankruptcy can be used to resolve mass litigation.
- The Sackler family faces potential increased financial liability and ongoing litigation.
- Supporters argue the ruling could lead to larger payouts for victims.
- The decision may prompt new legal strategies in bankruptcy cases.
Reason.com 
Portland Press Herald 
Forbes 
NBC News 
Boston Globe 
PBS NewsHour 
New York Daily News 
Benzinga 
Crooks and Liars 
SCOTUSblog Reason.com 
ARTnews 
Sherwood News Boston Globe 
GZERO Media 
San Francisco Chronicle 
USA TODAY 
Ars Technica 
UPI 
CBC 
Denver Gazette 
Newsweek 
Business Insider 
Raw Story 
BBC 
Financial Post 
Associated Press 
ABC News 
The Oregonian 
Al Jazeera 
New York Post 
South China Morning Post 
The Guardian Raw Story 
The New Civil Rights Movement 
Fox Business 
Rolling Stone 
Semafor 
Stat News 
The Daily Beast 
Los Angeles Times 
MSNBC 
HuffPost 
CNN 
The Mercury News 
Washington Post Forbes 
The Daily Caller ABC News USA TODAY 
CBS News Associated Press ABC News ABC News CNN ABC News ABC News NBC News 
Roll Call 
One America News Network 
Healio 
The Conversation 
